A new in‐situ remediation concept termed a Horizontal Reactive Media Treatment Well (HRX Well®) is presented that utilizes horizontal wells filled with reactive media to passively treat contaminated groundwater in‐situ. The approach involves the use of large‐diameter directionally drilled horizontal wells filled with granular reactive media generally installed parallel to the direction of groundwater flow. The design leverages natural “flow‐focusing” behavior induced by the high in‐well hydraulic conductivity of the reactive media relative to the aquifer hydraulic conductivity to passively capture and treat proportionally large volumes of groundwater within the well. Clean groundwater then exits the horizontal well along its downgradient sections. Many different types of solid granular reactive media are already available (e.g., zero valent iron, activated carbon, ion exchange resins, zeolite, apatite, chitin); therefore, this concept could be used to address a wide range of contaminants. Three‐dimensional flow and transport simulations were completed to assess the general hydraulic performance, capture zones, residence times, effects of aquifer heterogeneity, and treatment effectiveness of the concept. The results demonstrate that capture and treatment widths of up to tens of feet can be achieved for many aquifer settings, and that reductions in downgradient concentrations and contaminant mass flux are nearly immediate. For a representative example, the predicted treatment zone width for the HRX Well is approximately 27 to 44 feet, and contaminant concentrations immediately downgradient of the HRX Well decreased an order of magnitude within 10 days. A series of laboratory‐scale physical tests (i.e., tank tests) were completed that further demonstrate the concept and confirm model prediction performance. For example, the breakthrough time, peak concentration and total mass recovery of methylene blue (reactive tracer) was about 2, 35, and 20 times (respectively) less than chloride (conservative tracer) at the outlet of the tank‐scale HRX Well.
Evaluation of chemical risks to threatened and endangered species is a requirement for Superfund ecological risk assessments; however, screening levels to evaluate the potential for toxicity associated with ecological receptor exposure to per‐ and polyfluoroalkyl substances (PFAS) are lacking. Therefore, PFAS risk‐based screening levels (RBSLs) were developed. Wildlife RBSLs were developed using surrogate receptors selected to be representative of threatened and endangered species with different habitat types, feeding guilds, and trophic levels. Published uptake and toxicity data were combined with receptor exposure factors to derive RBSLs for terrestrial and aquatic wildlife for several PFAS, including perfluorononanoic acid, perfluorooctanesulfonic acid, perfluorooctanoic acid, perfluorohexanoic acid, perfluorobutanesulfonic acid, and pentafluorobenzoic acid. Uptake information for surrogate PFAS were considered to calculate RBSLs for PFAS with toxicity data and insufficient bioaccumulation data to develop an RBSL. Both no‐observed–adverse effect level (NOAEL)– and lowest‐observed–adverse effect level–based wildlife RBSLs were calculated to allow for a range of risk estimates appropriate to individual threatened and endangered species and populations of nonlisted wildlife receptors, respectively. Recommended water quality RBSLs protective of aquatic life were developed for 23 PFAS based on published literature reviews and peer‐reviewed aquatic toxicity studies and Great Lakes Initiative methodology. For wildlife receptors, NOAEL RBSLs ranged from to 0.013 to 340 mg/kg for soil, 0.0014 to 370 mg/kg for sediment, and 0.000075 to 1600 mg/L for surface water. For aquatic life, chronic RBSLs ranged from 0.00022 to 3.4 mg/L. For terrestrial plants and soil invertebrates, the no‐observed‐effect concentration screening levels range from 0.084 to 642 mg/kg and from 1 to 50 mg/kg, respectively. Environ Toxicol Chem 2021;40:921–936. © 2020 SETAC
A new in situ remediation concept termed a Horizontal Reactive Media Treatment Well (HRX Well®) is presented that utilizes a horizontal well filled with reactive media to passively treat contaminated groundwater in situ. The approach involves the use of a large‐diameter directionally drilled horizontal well filled with solid reactive media installed parallel to the direction of groundwater flow. The engineered contrast in hydraulic conductivity between the high in‐well reactive media and the ambient aquifer hydraulic conductivity results in the passive capture, treatment, and discharge back to the aquifer of proportionally large volumes of groundwater. Capture and treatment widths of up to tens of feet can be achieved for many aquifer settings, and reductions in downgradient concentrations and contaminant mass flux are nearly immediate. Many different types of solid‐phase reactive treatment media are already available (zero valent iron, granular activated carbon, biodegradable particulate organic matter, slow‐release oxidants, ion exchange resins, zeolite, apatite, etc.). Therefore, this concept could be used to address a wide range of contaminants. Laboratory and pilot‐scale test results and numerical flow and transport model simulations are presented that validate the concept. The HRX Well can access contaminants not accessible by conventional vertical drilling and requires no aboveground treatment or footprint and requires limited ongoing maintenance. A focused feasibility evaluation and alternatives analysis highlights the potential cost and sustainability advantages of the HRX Well compared to groundwater extraction and treatment systems or funnel and gate permeable reactive barrier technologies for long‐term plume treatment. This paper also presents considerations for design and implementation for a planned upcoming field installation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.